The subcutaneous biologic drugs and affiliated technologies market is projected to be worth over USD 180 billion by 2030, predicts Roots Analysis

Subcutaneous drug delivery, given the use of tailored formulation development solutions, has brought about a paradigm shift in at-home healthcare, enabling users to administer (life-saving) medications without having to rely on medical professionals.

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/subcutaneous-biologics-delivery/314.html
 

comments (0)

82 more from jameshebrew